Literature DB >> 23975436

Answer to the Letter to the Editor of H. Namazi concerning "Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts" by Lange T, Stehling C, Fröhlich B, Klingenhöfer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jürgens H, Schulte TL (2013), Eur Spine J;22(6):1417-1422.

T Lange1, T L Schulte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23975436      PMCID： PMC3804721          DOI： 10.1007/s00586-013-2956-5

Source DB:  PubMed          Journal:  Eur Spine J        ISSN： 0940-6719            Impact factor:   3.134


× No keyword cloud information.
  4 in total

Review 1.  Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.

Authors:  Roland Baron; Georges Rawadi
Journal:  Endocrinology       Date:  2007-03-29       Impact factor: 4.736

2.  The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1.

Authors:  Davide Gatti; Ombretta Viapiana; Luca Idolazzi; Elena Fracassi; Maurizio Rossini; Silvano Adami
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

3.  Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.

Authors:  Davide Gatti; Ombretta Viapiana; Elena Fracassi; Luca Idolazzi; Carmela Dartizio; Maria Rosaria Povino; Silvano Adami; Maurizio Rossini
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

4.  Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts.

Authors:  Tobias Lange; Christoph Stehling; Birgit Fröhlich; Mark Klingenhöfer; Philip Kunkel; Reinhard Schneppenheim; Gabriele Escherich; Georg Gosheger; Jendrik Hardes; Heribert Jürgens; Tobias L Schulte
Journal:  Eur Spine J       Date:  2013-03-01       Impact factor: 3.134
  4 in total
  3 in total

1.  Expert's comment concerning Grand Rounds case entitled "Aneurysmal bone cyst of C2 treated with novel anterior reconstruction and stabilization" by S. Rajasekaran et al. (Eur Spine J; 2016: DOI 10.1007/s00586-016-4518-0).

Authors:  Stefano Boriani
Journal:  Eur Spine J       Date:  2018-04-23       Impact factor: 3.134

2.  Denosumab: A bone antiresorptive drug.

Authors:  Navdeep Dahiya; Anjan Khadka; A K Sharma; A K Gupta; Nishith Singh; D B S Brashier
Journal:  Med J Armed Forces India       Date:  2014-03-24

Review 3.  Current Strategies for the Treatment of Aneurysmal Bone Cysts.

Authors:  Panagiotis Tsagozis; Otte Brosjö
Journal:  Orthop Rev (Pavia)       Date:  2015-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.